RankAlpha logo
Back to Rankings

VTGN

Vistagen TherapeuticsF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
VTGN vs peer average
20/100
VTGN vs. peer average (F vs. C)
Grade spread
A 1 · B 3 · F 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

VYNE is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $22.55M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerVYNEVYNE Therapeutics
VTGN
Vistagen Therapeutics
VYNE
VYNE Therapeutics
Grade
F
F
Momentum
7
36
Value
58
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs VYNE

VTGN / VYNE
Grade Position
Below peers
VTGN vs. peer average (F vs. C)
20/100
Momentum
7
VYNE
Value
58
VTGN
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs VTGN
1
VYNE
VYNE Therapeutics Inc Common
F
20/100
Even
2
AYTU
Aytu BioPharma Inc Common
A
100/100
-4
3
ZYBT
Zhengye Biotechnology Holding Ltd Class A Common
N/A
-
-
4
TXMD
TherapeuticsMD Inc Common
B
80/100
-3
5
BCTX
BriaCell Therapeutics Corp Common
F
20/100
Even
VYNE is the first peer returned for this comparison set.